5,223 reports of this reaction
2.3% of all DRS. HYDROCORTISONE reports
#4 most reported adverse reaction
CONDITION AGGRAVATED is the #4 most commonly reported adverse reaction for DRS. HYDROCORTISONE, manufactured by A2A Integrated Pharmaceuticals, LLC. There are 5,223 FDA adverse event reports linking DRS. HYDROCORTISONE to CONDITION AGGRAVATED. This represents approximately 2.3% of all 229,196 adverse event reports for this drug.
Patients taking DRS. HYDROCORTISONE who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is a less commonly reported adverse event for DRS. HYDROCORTISONE, but still significant enough to appear in the safety profile.
In addition to condition aggravated, the following adverse reactions have been reported for DRS. HYDROCORTISONE:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 5,223 FDA reports for DRS. HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 2.3% of all adverse event reports for DRS. HYDROCORTISONE, making it a notable side effect.
If you experience condition aggravated while taking DRS. HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.